Poland· PL-100068940

Unasyn

A sultamicillin product containing sultamicillinum, registered in Poland by Pfizer Europe MA EEIG. The same ATC class is registered in 3 of our 19 countries.

ATC J01CR04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedUnasynATCJ01CR04REGISTER NO.PL-100068940PACKS LISTED1CHECKEDAugust 23, 2026

Where it is registered

Sultamicillin is registered in 3 of 19 countries.

Countries holding a registration under ATC J01CR04 (sultamicillin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Sultamicillin · ATC J01CR04

3 / 19 countries

  • Czechiaprice
  • Germany
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Sultamicillinum
Manufacturer
Pfizer Europe MA EEIG
Country
Poland (PL)
ATC code
J01CR04
ATC class
Sultamicillin
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
August 23, 2026

Packs & prices · 1

  • gtin
    05909990065110

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sultamicillin in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sultamicillin products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Unasyn
  • Bulgaria · Уназин
  • Czechia · Unasyn
  • Germany · Sultamicillin Puren, Sultamicillin Ratiopharm
  • Estonia · Unasyn
  • Hungary · Unasyn
  • Italy · Unasyn
  • Lithuania · Unasyn
  • Romania · Unasyn
  • Slovakia · Bitammon, Unasyn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/df71106d-c2ef-4219-9fa3-069bbd5c8f6b
GET /v1/drugs/df71106d-c2ef-4219-9fa3-069bbd5c8f6b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "375 mg",
  "packaging": "05909990065110 ¦ Rp ¦ 10349\n12 tabl.\nRp ¦ Skasowane ¦ 10350\n10 tabl.",
  "substance": "Sultamycyllinum 375 mg",
  "common_name": "Sultamicillinum",
  "pl_product_id": "100068940",
  "pozwolenie_nr": "00651",
  "auth_procedure": "NAR",
  "authorisation_validity": "2023-08-24"
}

See everything about sultamicillin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.